Emma creates and manages patent portfolios for local start-ups and ASX listed companies, research institutes, and large multinational companies in the biotechnology, pharmaceutical, and materials science sectors.
Emma works closely with clients to clearly understand their business objectives so she can provide relevant commercial advice. She provides a coordinated strategic approach to achieve consistent and commercially valuable protection across multiple jurisdictions.
Her experience extends to all aspects of the patent lifecycle, including drafting and prosecution of patent applications, evidence preparation for use in opposition proceedings, as well as freedom to operate and validity opinions.
Prior to joining FPA, Emma completed her PhD at the University of Melbourne and the Ludwig Institute for Cancer Research, specialising in nanotechnology and biochemistry. Emma’s PhD studies involved the development of biocompatible semiconductor nanocrystals for use as bio-labels in cancer detection.
Emma has authored peer reviewed articles and reviews in journals such as ACS Nano, Small and the Journal of Molecular Biology. Articles can be viewed at the US National Library of Medicine, National Institutes of Health, National Center for Biotechnology Information (PubMed).
- Named as a ‘Rising Stars’ by IP Star, Managing Intellectual Property, 2019-2021
- Bachelor of Arts (Philosophy, Archaeology), University of Melbourne
- Bachelor of Science (Biochemistry) (First Class Honours), University of Melbourne
- PhD (Chemistry), University of Melbourne
- Master of Intellectual Property Law, University of Melbourne
- Registered Trans-Tasman Patent Attorney
- Institute of Patent & Trade Mark Attorneys of Australia (IPTA)